Tablo is Almost Home

Outset Medical released a study that the Tablo met both safety and efficacy endpoints for home. Currently FDA-cleared for use in hospitals and clinics, the new system is under evaluation by FDA for home dialysis use.

Read the full article » | Posted 11-16-2019

Related Articles

• Byonyks’ X1 APD Cycler Received FDA 510(k) Approval Last Summer Posted 02-17-2026
• FDA granted 510(k) approval to Outset for Next generation Tablo with Cybersecurity Posted 02-17-2026
• Drs. Monica Farcus and Jeffrey Perl Win the Mitchell Award for Health System Innovation Posted 01-16-2026
• Nephrodite Wins FDA Breakthrough Device Designation for “Holly” Posted 01-16-2026